Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Hypothalamic dysfunction


See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

Treatment

Medical Products

The medication(s) listed in the table(s) below have been approved by the Food and Drug Administration (FDA) for treatment of this condition. The FDA Office of Orphan Products Development designates "orphan products" for those that treat rare diseases affecting fewer than 200,000 Americans. The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products. To search for all FDA approved drugs, visit Drugs@FDA. You can find orphan products used to treat other conditions by searching the Orphan Drug Product Designation database.


Generic Name Follitropin alfa, recombinant
Trade Name
(Manufacturer Name)
Gonal-f®
(EMD Serono, Inc.)
Indication
The FDA has approved this product to be used in this manner.
For the induction of spermatogenesis in men with primary and secondary hypogonadotropic hypogonadism in whom the cause of infertility is not due to primary testicular failure.
More Information about this product Drug Information Portal

Generic Name Gonadorelin acetate
Trade Name
(Manufacturer Name)
Lutrepulse
(Ferring Laboratories, Inc.)
Indication
The FDA has approved this product to be used in this manner.
For induction of ovulation in women with hypothalamic amenorrhea due to a deficiency or absence in the quantity or pulse pattern of endogenous GnRH secretion.
More Information about this product Drug Information Portal

See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.